Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigen processing and presentation in the eye: a review.

J Liversidge1, J V Forrester

  • 1Department of Ophthalmology, University of Aberdeen Medical School, Foresterhill, UK.

Current Eye Research
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colitis in a transgenic mouse model of autoimmune uveitis may be induced by neoantigen presentation in the bowel.

Scientific reports·2023
Same author

Low-dose 2-deoxy glucose stabilises tolerogenic dendritic cells and generates potent in vivo immunosuppressive effects.

Cellular and molecular life sciences : CMLS·2020
Same author

Scientific Business Abstracts of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland.

QJM : monthly journal of the Association of Physicians·2019
Same author

The atypical chemokine receptor-2 does not alter corneal graft survival but regulates early stage of corneal graft-induced lymphangiogenesis.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2018
Same author

Bowman lecture on the role of inflammation in degenerative disease of the eye.

Eye (London, England)·2013
Same author

The third international symposium on ocular inflammation.

Ocular immunology and inflammation·2012

Understanding T cell receptor usage in autoimmune uveitis is key for immunotherapy. This study shows Major Histocompatibility Complex (MHC) class II molecules restrict T cell responses to retinal antigens, influencing autoimmune disease progression.

Area of Science:

  • Immunology
  • Ophthalmology
  • Autoimmune Diseases

Background:

  • T cell receptor (TCR) recognition of self-antigen/MHC complexes is a target for autoimmune disease immunotherapy.
  • Successful immunotherapy for uveoretinitis requires uniform TCR usage, restricted MHC usage, and limited epitope recognition.

Purpose of the Study:

  • To investigate T cell responses to retinal antigens in the context of Major Histocompatibility Complex (MHC) class II restriction.
  • To explore the processing of retinal antigens and the role of retinal pigment epithelium (RPE) cells in ocular inflammation.

Main Methods:

  • Analysis of T cell proliferation in response to retinal antigens.
  • Investigation of antigen processing using protease inhibitors.
  • Assessment of prostaglandin E2 (PGE2) production by RPE cells.

Related Experiment Videos

Main Results:

  • T cell proliferation to retinal antigens was restricted by the IA MHC class II molecule, despite clonal heterogeneity.
  • Differential reactivity patterns to retinal antigens were observed with various protease inhibitors.
  • Natural processing of interphotoreceptor retinoid-binding protein (IRBP) is complex, while S-antigen processing may involve plasmin.
  • Retinal pigment epithelium (RPE) cells produce PGE2, suggesting a potential suppressive role in ocular inflammation.

Conclusions:

  • MHC class II restriction plays a significant role in T cell responses during autoimmune uveitis.
  • Antigen processing pathways and RPE cell-mediated suppression are critical factors in the pathogenesis of ocular inflammation.